These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 20139743)

  • 1. Ureteral stenosis after postprostatectomy intensity-modulated radiotherapy.
    Cohen KH; Teh BS; Paulino AC; Butler EB
    Am J Clin Oncol; 2010 Feb; 33(1):108. PubMed ID: 20139743
    [No Abstract]   [Full Text] [Related]  

  • 2. Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy.
    Goenka A; Magsanoc JM; Pei X; Schechter M; Kollmeier M; Cox B; Scardino PT; Eastham JA; Zelefsky MJ
    Eur Urol; 2011 Dec; 60(6):1142-8. PubMed ID: 21855208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative toxicity and dosimetric profile of whole-pelvis versus prostate bed-only intensity-modulated radiation therapy after prostatectomy.
    Deville C; Vapiwala N; Hwang WT; Lin H; Ad VB; Tochner Z; Both S
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1389-96. PubMed ID: 21664069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Image Guided Hypofractionated Postprostatectomy Intensity Modulated Radiation Therapy for Prostate Cancer.
    Lewis SL; Patel P; Song H; Freedland SJ; Bynum S; Oh D; Palta M; Yoo D; Oleson J; Salama JK
    Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):605-11. PubMed ID: 26867889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy.
    Wong GW; Palazzi-Churas KL; Jarrard DF; Paolone DR; Graf AK; Hedican SP; Wegenke JD; Ritter MA
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):449-55. PubMed ID: 17869014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate-specific antigen doubling time subsequent to radical prostatectomy is a predictor of outcome following salvage external beam radiation therapy: a single-centre experience.
    Servoll E; Sæter T; Vlatkovic L; Nesland JM; Waaler G; Axcrona K
    Scand J Urol; 2015 Jun; 49(3):218-23. PubMed ID: 25428750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intensity-modulated radiotherapy: the gold standard for postprostatectomy irradiation?
    Bossi A; De Meerleer G; Ost P
    Eur Urol; 2011 Dec; 60(6):1149-50; discussion 1150-1. PubMed ID: 21920662
    [No Abstract]   [Full Text] [Related]  

  • 8. A matched control analysis of adjuvant and salvage high-dose postoperative intensity-modulated radiotherapy for prostate cancer.
    Ost P; De Troyer B; Fonteyne V; Oosterlinck W; De Meerleer G
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1316-22. PubMed ID: 20675081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Salvage radiotherapy in rising PSA after radical prostatectomy].
    Carrie C; Pommier P
    Cancer Radiother; 2007 Nov; 11(6-7):370-2. PubMed ID: 17869564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how?
    Créhange G; Roach M; Martin E; Cormier L; Peiffert D; Cochet A; Chapet O; Supiot S; Cosset JM; Bolla M; Chung HT
    Cancer Radiother; 2014 Oct; 18(5-6):524-34. PubMed ID: 25192626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of second malignancies after modern radiotherapy versus prostatectomy for localized prostate cancer.
    Huang J; Kestin LL; Ye H; Wallace M; Martinez AA; Vicini FA
    Radiother Oncol; 2011 Jan; 98(1):81-6. PubMed ID: 20951450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radical prostatectomy vs. intensity-modulated radiation therapy in the management of localized prostate adenocarcinoma.
    Aizer AA; Yu JB; Colberg JW; McKeon AM; Decker RH; Peschel RE
    Radiother Oncol; 2009 Nov; 93(2):185-91. PubMed ID: 19800702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy.
    De Meerleer G; Fonteyne V; Meersschout S; Van den Broecke C; Villeirs G; Lumen N; Ost P; Vandecasteele K; De Neve W
    Radiother Oncol; 2008 Nov; 89(2):205-13. PubMed ID: 18771809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose salvage intensity-modulated radiotherapy with or without androgen deprivation after radical prostatectomy for rising or persisting prostate-specific antigen: 5-year results.
    Ost P; Lumen N; Goessaert AS; Fonteyne V; De Troyer B; Jacobs F; De Meerleer G
    Eur Urol; 2011 Oct; 60(4):842-9. PubMed ID: 21514039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives on the natural history of recurrent prostate cancer after radical prostatectomy, based on the response to salvage radiotherapy.
    Stephenson AJ; Slawin KM; Bianco FJ; Scardino PT
    BJU Int; 2004 Dec; 94(9):1210-2. PubMed ID: 15610088
    [No Abstract]   [Full Text] [Related]  

  • 16. Toxicity analysis of postoperative image-guided intensity-modulated radiotherapy for prostate cancer.
    Nath SK; Sandhu AP; Rose BS; Simpson DR; Nobiensky PD; Wang JZ; Millard F; Kane CJ; Parsons JK; Mundt AJ
    Int J Radiat Oncol Biol Phys; 2010 Oct; 78(2):435-41. PubMed ID: 19939580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage intensity modulated radiotherapy using endorectal balloon after radical prostatectomy: clinical outcomes.
    Ishiyama H; Teh BS; Blanco AI; Paulino AC; Mai WY; Caillouet J; Xu B; Butler EB
    Int J Urol; 2013 Dec; 20(12):1178-83. PubMed ID: 23573867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute toxicity in high-risk prostate cancer patients treated with androgen suppression and hypofractionated intensity-modulated radiotherapy.
    Pervez N; Small C; MacKenzie M; Yee D; Parliament M; Ghosh S; Mihai A; Amanie J; Murtha A; Field C; Murray D; Fallone G; Pearcey R
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):57-64. PubMed ID: 19395192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial.
    Massaccesi M; Cilla S; Deodato F; Digesù C; Macchia G; Caravatta L; Ippolito E; Picardi V; Ferro M; Mignogna S; Mattiucci GC; Valentini V; Piermattei A; Morganti AG
    Anticancer Res; 2013 Jun; 33(6):2785-9. PubMed ID: 23749942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Radiotherapy for local recurrences of prostate cancer after radical prostatectomy].
    Grishina YA; Khmelevsky EV
    Vopr Onkol; 2015; 61(1):7-13. PubMed ID: 26016138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.